Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers

Abstract

Recent studies on small series of pancreatic cancer (PC) with foci of pancreatic intraepithelial neoplasia (PanIN), a putative precursor lesion, have shown that multiple K-RAS mutations may coexist in the same neoplastic pancreas. To see whether mutant-K-RAS polyclonality is a common and specific feature of pancreatic carcinogenesis, we investigated a unselected series of periampullary cancers (41 pancreatic, 13 biliary and two ampullary adenocarcinomas). After hemi-nested polymerase chain reaction (PCR), mutations identified with single strand conformation polymorphism (SSCP) were confirmed by allele-specific PCR and sequencing. K-RAS codon 12 was mutated in 34 (83%) pancreatic cancers and in 11 (85%) biliary cancers. Multiple distinct K-RAS mutations were found in 16 PC (39% of all cases, 47% of those with mutated K-RAS) and in eight biliary cancers (62 and 72%, respectively). In PC, multiple K-RAS mutations were more frequent (P<0.001) in cancers with (nine of 12, 75%) than in those without detectable PanIN (seven of 29, 24%). Individual precursor lesions of the same neoplastic pancreas were found to harbor distinct mutations. Results show that multiple K-RAS mutations are frequent both in PC with associated PanIN and in biliary cancers, and indicate that clonally distinct precursor lesions of PC might variably contribute to tumor development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M . 1988 Cell 53: 549–554

  • Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE . 1994 Cancer Res. 54: 3568–3573

  • Cubilla AL, Fitzgerald PJ . 1976 Cancer Res. 36: 2690–2698

  • Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M . 1987 Nature 327: 298–303

  • Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL . 1993 Am. J. Pathol. 143: 545–554

  • Hruban RH, Goggins M, Parsons J, Kern SE . 2000a Clin. Cancer Res. 6: 2969–2972

  • Hruban RH, Wilentz RE, Kern SE . 2000b Am. J. Pathol. 156: 1821–1825

  • Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman ES, Kern SE, Klimstra DS, Kloppel G, Longnecker DS, Luttges J, Offerhaus GJA . 2001 Am. J. Surg. Pathol. 25: 579–586

  • Kern SE . 1998 Current Opinion Oncology 10: 74–80

  • Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CJ . 1991 Cancer Res. 51: 3497–3502

  • Moskaluk CA, Hruban RH, Kern SE . 1997 Cancer Res. 57: 2140–2143

  • Motojma K, Tsunoda T, Kanematsu T, Nagata Y, Urano T, Shiku H . 1991 Ann. Surg. 214: 657–662

  • Rozemblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE . 1997 Cancer Res. 57: 1731–1734

  • Sherratt EJ, Thiomas AW, Gagg JW, Alcolado JC . 1996 Biotechniques 20: 430–432

  • Sugano K, Kyogoku A, Fukayama N, Ohkura H, Shimosato Y, Sekiya T, Hayashi K . 1993 Lab. Invest. 68: 361–366

  • Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, Sninsky JJ . 1993 Cancer Res. 53: 2472–2474

  • Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, Yoshida H, Machinami R, Kishi K, Omata M . 1996 Gastroenterology 110: 227–231

  • Urrutia R, Di Magno EP . 1996 Gastroenterology 110: 306–310

  • Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T . 1994 Gastroenterology 107: 1147–1153

  • Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T . 2000 Am. J. Pathol. 156: 2123–2133

  • Yanagisawa A, Ohtake K, Hori M, Kitagawa T, Sugano H, Kato Y . 1993 Cancer Res. 53: 953–956

  • Yashiro M, Carethers JM, Laghi L, Saito K, Slezak P, Jaramillo E, Rubio C, Koizumi K, Hirakawa K, Boland CR . 2001 Cancer Res. 61: 2676–2683

  • Zhu D, Keohavong P, Finkelstein SD, Swalsky P, Bakker A, Weissfeld J, Srivastava S, Whiteside TL . 1997 Cancer Res. 57: 2485–2492

Download references

Acknowledgements

This work was partially supported by Consiglio Nazionale Ricerche (CNR), grand number 95.02323.CT04.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alberto Malesci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laghi, L., Orbetegli, O., Bianchi, P. et al. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Oncogene 21, 4301–4306 (2002). https://doi.org/10.1038/sj.onc.1205533

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205533

Keywords

This article is cited by

Search

Quick links